Jennifer N. Durham

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

MedicineNursingBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer”.

T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3372

N/A

2.7DataRank · unranked

117 citations

Matthew C. Dallos, Marianna Zahurak, Alan W. Partin, Edward M. Schaeffer, Ashley E. Ross +14 more

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-39196-9

N/A

1.4DataRank · unranked

87 citations

Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson +24 more

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Science(2017)10.1126/science.aan6733

N/A

1.3DataRank · unranked

6550 citations

Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh +46 more

Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial

Nature Communications(2024)10.1038/s41467-024-52528-7

N/A

1.0DataRank · unranked

42 citations

Ludmila Danilova, Jennifer N. Durham, Courtney B. Betts, Leslie Cope, Dimitrios N. Sidiropoulos +19 more

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy

Cancer Cell(2022)10.1016/j.ccell.2022.10.001

N/A

0.778DataRank · unranked

178 citations

Joseph A. Tandurella, Jessica Gai, Qingfeng Zhu, Su Jin Lim, Dwayne L. Thomas +26 more

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3978

N/A

0.756DataRank · unranked

153 citations

Todd S. Crocenzi, Jennifer N. Durham, Elizabeth A. Sugar, Annie A. Wu, Beth Onners +16 more

Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0343

N/A

0.722DataRank · unranked

12 citations

Su Jin Lim, Jennifer N. Durham, Ana De Jesus‐Acosta, Katherine M. Bever, Daniel A. Laheru +6 more

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

Nature Immunology(2024)10.1038/s41590-024-01992-w

N/A

0.695DataRank · unranked

102 citations

Won Jin Ho, Luciane T. Kagohara, Alexander A. Girgis, Sarah M. Shin, Ludmila Danilova +34 more

Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2974

N/A

0.655DataRank · unranked

78 citations

Ding Ding, Barish H. Edil, Carol Judkins, Jennifer N. Durham, Dwayne L. Thomas +32 more

Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009734

N/A

0.574DataRank · unranked

18 citations

Soren Charmsaz, Howard L. Li, Hua‐Ling Tsai, Ludmila Danilova, Kabeer Munjal +29 more

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0225

N/A

0.554DataRank · unranked

18 citations

Marianna Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth I. Heath +18 more

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

Journal of Clinical Investigation(2024)10.1172/jci176567

N/A

0.500DataRank · unranked

27 citations

Soren Charmsaz, Stephanie Alden, Madelena Brancati, Howard L. Li, Aanika Balaji +38 more

Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000932

N/A

0.483DataRank · unranked

24 citations

Gaurav Sharma, Qingfeng Zhu, Genevieve L. Stein-O’Brien, Jennifer N. Durham, Robert A. Anders +8 more

Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.335

N/A

0.470DataRank · unranked

22 citations

Qingfeng Zhu, Jennifer N. Durham, Nicole Groß, Soren Charmsaz, James M. Leatherman +14 more

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.16.562104

N/A

0.434DataRank · unranked

17 citations

Won Jin Ho, Luciane T. Kagohara, Alexander A. Girgis, Sarah M. Shin, Ludmila Danilova +29 more

A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages

OncoImmunology(2025)10.1080/2162402x.2025.2543614

N/A

0.425DataRank · unranked

16 citations

Sarah M. Shin, Jennifer N. Durham, Hanfei Qi, Alexei Hernandez, Erin M. Coyne +19 more

Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0002

N/A

0.396DataRank · unranked

13 citations

Won Jin Ho, Daniel Shu, Jennifer N. Durham, Madelena Brancati, Heather Davis Bruning +23 more

Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.558

N/A

0.345DataRank · unranked

9 citations

Carol Judkins, Su Jin Lim, Hao Wang, Rose Parkinson, Jessica Gai +15 more

1833P Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2781

N/A

0DataRank · unranked

0 citations

M.L. Zahurek, Adel Mandl, Michelle A. Rudek, Elisabeth I. Heath, Catherine H. Marshall +13 more

Data from Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma

(2023)10.1158/2767-9764.c.6550898.v1

N/A

0DataRank · unranked

0 citations

Su Jin Lim, Jennifer N. Durham, Ana De Jesus‐Acosta, Katherine M. Bever, Daniel A. Laheru +6 more

A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.01.015

N/A

0DataRank · unranked

1 citations

Neha Verma, Maureen Berg, Jeanne Harrison, Peng Huang, James M. Leatherman +11 more